New Insights Reveal Primary Messengers in Fear Response
Recent studies involving live mice indicate that neuropeptides, not neurotransmitters, play the chief role in the brain’s "fear circuit."
Unveiling a New Mechanism
When we touch a hot object, pain signals rush through our spinal cord to the amygdala, our brain's fear center. This triggers an emotional response, crucial for learning to avoid danger. Unfortunately, in conditions such as PTSD or severe anxiety, this mechanism functions erratically.
Historically, treatments for these disorders have adjusted fast-acting neurotransmitters, believed essential for pain, fear, and threat responses. However, a recent "Cell" – published study challenges this assumption. Sung Han from the Salk Institute and his team proposed that slower-acting neuropeptides might be key. Lacking the tools to study these molecules comprehensively, the researchers innovated new methods.
Pivotal Discoveries Through Innovative Tools
Neurons quickly pass signals using neurotransmitters which open ion channels in neighboring cells. Conversely, neuropeptides, shipped in larger packets (large dense core vesicles or LDCVs), initiate gene activity when they bind to receptors. While many have seen neuropeptides as minor players assisting neurotransmitters, Han suspected otherwise.
By developing tools to visualize LDCV release and silence specific neuropeptides at will, Han's team revealed surprising results: neuropeptides play a central part in driving the fear response.
Experimental Validation in Live Mice
Mice conditioned to fear a foot shock displayed expected freezing behavior when exposed to a related sound. The researchers analyzed fear responses with neuropeptides silenced versus the neurotransmitter glutamate. Glutamate alteration had no effect, while silencing neuropeptides eliminated the fear response for an entire day. This firmly pointed to neuropeptides as primary messengers for fear signaling.
Dr. Robert Edwards of the University of California attested that this territory was indeed uncharted, and new findings highlighted neuropeptides’ significance.
Towards Better Treatments
Most neurotransmitters are packaged solo, but researchers found multiple neuropeptides in a single vesicle. Silencing all, rather than one, significantly reduced fear, suggesting multi-targeted treatments for awe, panic, and PTSD might be more efficient.
Han advocates for treatments addressing multiple neuropeptide receptors, potentially ushering in advances in handling anxiety, PTSD, and pain.
By focusing on neuropeptides, researchers aim to pioneer more effective remedies for fear-based disorders, opening new avenues in drug development.
Earlier, SSP wrote that 3D-printed blood vessels bring artificial organs closer to reality.
